Femme et Homme
- | Pays :
- Bulgaria
- Singapore
- Lithuania
- Les 10 autres...
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to demonstrate the superiority of MCI-196 over placebo and non-inferiority with simvastatin in reducing serum low-density lipoprotein (LDL)-cholesterol in subjects with chronic kidney disease Stage V on dialysis. This study incorporates a Washout Period and two treatment periods - an active comparison phase and a placebo-controlled withdrawal phase.
Critère d'inclusion
- chronic kidney disease